01Market Access & Product Innovation

From molecule to market, without the detours.

We partner with pharma and biotech teams to bring new health products to market faster — proprietary delivery systems, formulation and R&D co-development, and regulatory entry into the niche and emerging markets where local expertise decides everything.

Artist interpretation Hart‑S® · Sildenafil 50 mg oral strip
< 60 sdissolves — no water needed
Clinically proven
Image for illustrative purposes only
Built & backed by Clinically validated Patent-protected ODS Regulatory pathways Regional network Trusted by pharma · biotech · public-health partners
02What we do

Innovation and access, under one accountable partner

01 / 04

R&D & Co-Development

  • ODS formulation & licensing
  • Custom formulation & reformulation
  • In-house testing & tech transfer
  • Paediatric / geriatric adaptation
  • Adapting actives for low-access settings
02 / 04

Regulatory & Market Entry

We assist in supporting for local registration and regulatory compliance requirement.

03 / 04

Specialty Market Access

A reach into high-need therapeutic areas — oncology, rare disease, and humanitarian channels — through an established regional network of distributors and clinical stakeholders.

04 / 04

Proprietary Devices & Supplies

We develop and license proprietary medical devices and wellness products that complement pharma offerings — from novel delivery systems to patient-ready packaging formats.

03Flagship platform
Product image — Hart‑S® oral disintegrating strip on tongue / pack shot Hart‑S® · Oral disintegrating strip
Proprietary · Oral Disintegrating Strip (ODS)

Hart‑S®: a dose that dissolves in seconds

Our proprietary oral disintegrating strip delivers Hart‑S® (Sildenafil 50 mg) — and other actives — as a rapid-dissolve film that needs no water. Built for paediatric, geriatric, and low-compliance patients, and heat-stable for tropical markets where conventional tablets struggle.

No water required
High absorption efficiency
Precise micro-dosing
Heat-stable for tropical markets
Read the peer-reviewed clinical results
50 mgValidated active dose
< 60 sOral disintegration
Peer‑reviewedPublished clinical study

Image for illustrative purposes only

04How we work

One path from concept to commercialization

A single team carries your product through every stage — so nothing is lost in the hand-off between formulation, regulatory, and market.

1

Concept & formulation

We assess the molecule and target population, then formulate — or reformulate — for the delivery format that fits.

2

Development & testing

In-house bench testing, stability work, and tech transfer move the product from lab to scalable production.

3

Regulatory & dossier

Support for local registration and regulatory compliance requirement.

4

Market access & launch

Supply chain and logistic coordination support.

05Partner with us

Let's chat!

Whether you're launching a novel therapy or adapting an existing drug for new populations, tell us where you're headed and we'll map the route — formulation, approval, and access.

Speak with our innovation team

+65 6515 6516
2 Corporation Rd, #03-4/05, Singapore 618494